DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.43−0.45 (-3.79%)
Close on Nov 12, 2026Market cap $718.69MP/E –Yield –
DBV Technologies operating margin
Operating margin is operating income as a percentage of revenue.
DBV Technologies's operating margin for the twelve months ending Sep 30, 2026 was -5431.6%. For fiscal 2025 it was -2609.2%, against -2808.7% the year before. The highest annual figure on record is -486.0% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2609.2% | +199.5 |
| FY2024 | Dec 31, 2024 | -2808.7% | −2322.7 |
| FY2023 | Dec 31, 2023 | -486.0% | +1508.9 |
| FY2022 | Dec 31, 2022 | -1994.9% | −267.2 |
| FY2021 | Dec 31, 2021 | -1727.6% | −319.0 |
| FY2020 | Dec 31, 2020 | -1408.7% | −245.9 |
| FY2019 | Dec 31, 2019 | -1162.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -4050.0% | −2825.0 |
| Q2 FY2026 | Jun 30, 2026 | -7228.6% | −4488.6 |
| Q1 FY2026 | Mar 31, 2026 | -5322.2% | −1997.2 |
| Q4 FY2025 | Dec 31, 2025 | -7084.3% | −2414.8 |
| Q3 FY2025 | Sep 30, 2025 | -1225.0% | +1604.1 |
| Q2 FY2025 | Jun 30, 2025 | -2740.0% | +174.9 |
| Q1 FY2025 | Mar 31, 2025 | -3325.0% | −1295.3 |
| Q4 FY2024 | Dec 31, 2024 | -4669.5% | −4535.2 |
| Q3 FY2024 | Sep 30, 2024 | -2829.1% | −2058.9 |
| Q2 FY2024 | Jun 30, 2024 | -2914.9% | −1818.9 |
| Q1 FY2024 | Mar 31, 2024 | -2029.7% | −1065.0 |
| Q4 FY2023 | Dec 31, 2023 | -134.3% | +734.5 |
| Q3 FY2023 | Sep 30, 2023 | -770.2% | +787.8 |
| Q2 FY2023 | Jun 30, 2023 | -1096.0% | −437.3 |
| Q1 FY2023 | Mar 31, 2023 | -964.7% | −505.0 |
| Q3 FY2022 | Sep 30, 2022 | -868.9% | +973.0 |
| Q2 FY2022 | Jun 30, 2022 | -1558.1% | −550.5 |
| Q1 FY2022 | Mar 31, 2022 | -658.7% | +57.1 |
| Q4 FY2021 | Dec 31, 2021 | -459.7% | +861.5 |
| Q3 FY2021 | Sep 30, 2021 | -1841.9% | −968.5 |
| Q1 FY2021 | Mar 31, 2021 | -1007.6% | – |
| Q3 FY2020 | Sep 30, 2020 | -715.8% | – |
| Q2 FY2020 | Jun 30, 2020 | -1321.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -873.3% | – |
See a number that looks wrong?